Sándor Kolok

620 citations

27 papers · 424 indexed · h-index 14

Co-authors: András Mihály Boros József Nagy Zsolt Szombathelyi György Domány Anikó Gere Sándor Farkas László Fodor István Greiner
Topics: Neuroscience and Neuropharmacology Research (18 papers)Pharmacological Receptor Mechanisms and Effects (9 papers)Receptor Mechanisms and Signaling (9 papers)
Cited by: Cellular and Molecular Neuroscience Biological Psychiatry Toxicology
Journals: Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics European Journal of Medicinal Chemistry
Partner nations: Hungary Netherlands Japan

In The Last Decade

Sándor Kolok

26 papers receiving 405 citations

Peers

Countries citing papers authored by Sándor Kolok

Since Specialization

Citations

This map shows the geographic impact of Sándor Kolok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sándor Kolok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sándor Kolok more than expected).

Fields of papers citing papers by Sándor Kolok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sándor Kolok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sándor Kolok. The network helps show where Sándor Kolok may publish in the future.

Co-authorship network of co-authors of Sándor Kolok

This figure shows the co-authorship network connecting the top 25 collaborators of Sándor Kolok. A scholar is included among the top collaborators of Sándor Kolok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sándor Kolok. Sándor Kolok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of dihydropyrazino-benzimidazole derivatives as metabotropic glutamate receptor-2 (mGluR2) positive allosteric modulators (PAMs) 2019 ·European Journal of Medicinal Chemistry ·György Szabó,Sándor Kolok,(unknown),Mónika Vastag,Zoltán Béni,János Kóti,Katalin Sághy,György Lévay,István Greiner,György M. Keserű	5
2	4-Aryl-3-arylsulfonyl-quinolines as negative allosteric modulators of metabotropic GluR5 receptors: From HTS hit to development candidate 2016 ·Bioorganic & Medicinal Chemistry Letters ·János Galambos,György Domány,(unknown),(unknown),György M. Keserű,(unknown),Sándor Kolok,(unknown),Mónika Vastag,Katalin Sághy,János Kóti,Zoltán Szakács,Zoltán Béni,Krisztina Gál,Zsolt Szombathelyi,István Greiner	18
3	New P2X3 receptor antagonists. Part 1: Discovery and optimization of tricyclic compounds 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),(unknown),Sándor Kolok,Mónika Vastag,Attila Cselenyák	4
4	New P2X3 receptor antagonists. Part 2: Identification and SAR of quinazolinones 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Sándor Kolok,Mónika Vastag	5
5	Thieno[2,3-b]pyridines as negative allosteric modulators of metabotropic GluR5 receptors: Lead optimization 2015 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),György Domány,(unknown),(unknown),Sándor Kolok,(unknown),Mónika Vastag,Katalin Sághy,István Gyertyán,János Kóti,Krisztina Gál,Sándor Farkas,György M. Keserű,István Greiner,Zsolt Szombathelyi	14
6	Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α2C receptor 2014 ·Brain Research Bulletin ·(unknown),(unknown),József Nagy,Balázs Lendvai,Sándor Kolok	8
7	Thieno[2,3-b]pyridines as negative allosteric modulators of metabotropic GluR5 receptors: Hit-to-lead optimization 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),György Domány,(unknown),(unknown),Béla Kiss,Sándor Kolok,(unknown),István Gyertyán,Viktor Háda,János Kóti,Krisztina Gál,Sándor Farkas,György M. Keserű,István Greiner,Zsolt Szombathelyi	7
8	Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·János Éles,(unknown),(unknown),Éva Bozó,(unknown),Ákos Tarcsay,Sándor Kolok,Éva Schmidt,Mónika Vastag,(unknown),Sándor Farkas,György Domány,György M. Keserű	20
9	Hit-to-lead optimization of disubstituted oxadiazoles and tetrazoles as mGluR5 NAMs 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Csaba Wéber,(unknown),(unknown),(unknown),László Molnár,(unknown),Attila Horváth,Béla Kiss,Sándor Kolok,József Nagy,(unknown),Krisztina Gál,István Greiner,Zsolt Szombathelyi,György M. Keserű,György Domány	18
10	Carbamoyloximes as novel non-competitive mGlu5 receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·János Galambos,(unknown),(unknown),(unknown),László Molnár,(unknown),Attila Horváth,Béla Kiss,Sándor Kolok,József Nagy,(unknown),(unknown),Mónika Vastag,Katalin Sághy,István Gyertyán,Krisztina Gál,István Greiner,Zsolt Szombathelyi,György M. Keserű,György Domány	20
11	Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Sándor Kolok,Anikó Gere,József Nagy,László Fodor,(unknown),József Fetter,(unknown),Béla Ágai,C Horváth,Sándor Farkas,György Domány	14
12	Functional characterization of sodium channel blockers by membrane potential measurements in cerebellar neurons: Prediction of compound preference for the open/inactivated state 2006 ·Neurochemistry International ·Sándor Kolok,J.I. Nagy,Zsolt Szombathelyi,(unknown)	11
13	Kynurenic acid amides as novel NR2B selective NMDA receptor antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Sándor Kolok,(unknown),Anikó Gere,C Horváth,Sándor Farkas,István Greiner,György Domány	33
14	Indole-2-carboxamidines as novel NR2B selective NMDA receptor antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Sándor Kolok,(unknown),István Greiner,Gábor Tárkányi,(unknown),C Horváth,Sándor Farkas,György Domány	15
15	Role of Altered Structure and Function of NMDA Receptors in Development of Alcohol Dependence 2005 ·Current Neuropharmacology ·Judit Nagy,Sándor Kolok,András Mihály Boros,(unknown)	22
16	Tolperisone-Type Drugs Inhibit Spinal Reflexes via Blockade of Voltage-Gated Sodium and Calcium Channels 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Pál Kocsis,Sándor Farkas,László Fodor,(unknown),Márta Thán,Sándor Kolok,Anikó Gere,(unknown),István Tarnawa	50
17	Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors 2005 ·Neurochemistry International ·(unknown),(unknown),András Mihály Boros,Sándor Kolok,László Fodor,József Nagy,Zsolt Szombathelyi	10
18	Inducible expression and pharmacology of recombinant NMDA receptors, composed of rat NR1a/NR2B subunits 2003 ·Neurochemistry International ·József Nagy,András Mihály Boros,(unknown),Sándor Kolok,László Fodor	19
19	Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Sándor Kolok,Anikó Gere,Éva Ágai-Csongor,Béla Ágai,Gábor Tárkányi,C Horváth,(unknown),Éva Bozó,(unknown),(unknown),József Nagy,Sándor Farkas,György Domány	23
20	Differential alterations in the expression of NMDA receptor subunits following chronic ethanol treatment in primary cultures of rat cortical and hippocampal neurones 2002 ·Neurochemistry International ·József Nagy,Sándor Kolok,(unknown),András Mihály Boros,Zsolt Szombathelyi	41

About Sándor Kolok

Sándor Kolok is a scholar working on Cellular and Molecular Neuroscience, Toxicology and Physiology, having authored 27 papers that have together received 424 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (18 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Receptor Mechanisms and Signaling (9 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (195 citations), Biological Psychiatry (24 citations) and Toxicology (18 citations). Sándor Kolok has collaborated with scholars based in Hungary, Netherlands and Japan. Frequent co-authors include András Mihály Boros, József Nagy, Zsolt Szombathelyi, György Domány, Anikó Gere, Sándor Farkas, László Fodor, István Greiner, György M. Keserű and C Horváth. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact